lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Plasma BNP and Diuretics As Predictors of Cardiovascular Events in Patients with MI and IGT

68 Pages Posted: 31 Mar 2019

See all articles by Kazuhiro Shindo

Kazuhiro Shindo

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Hiroki Fukuda

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Tatsuro Hitsumoto

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Shin Ito

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Akira Ishii

Osaka University

Masanori Asakura

Hyogo College of Medicine - Department of Cardiovascular Division; National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development; National Cerebral and Cardiovascular Centre - Department of Cardiovascular Medicine; Hiroshima City Hospital - Department of Cardiology; Saitama Prefecture Cardiovascular and Respiratory Center - Department of Cardiology

Jiyoong Kim

Kim Cardiovascular Clinic; National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development; Hiroshima City Hospital - Department of Cardiology; Showa Medical University, Showa University Hospital, Department of Medicine, Division of Cardiology

Hiroshi Asanuma

Meiji University of Intergrative Medicine - Department of Internal Medicine

Osamu Tsukamoto

Osaka University - Graduate School of Medicine

Takashi Washio

Osaka University

Masafumi Kitakaze

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

More...

Abstract

Background: Impaired glucose tolerance (IGT) promotes cardiovascular events in myocardial infarction (MI) patients. However, our randomized trial (the ABC study) showed that alpha-glucosidase inhibitors do not prevent cardiovascular events in patients with MI and IGT. The aim of the present study is to identify potential clinical factors for cardiovascular and coronary events in patients with a MI and IGT.

Methods: Using the limitless-arity multiple testing procedure, an artificial intelligence (AI)-based data mining method, we analyzed 385,391 combinations of fewer than four clinical parameters.

Findings: We identified 380 combinations predicting the occurrence of (1) all-cause hospitalisation, (2) hospitalisation due to worsening of heart failure (HF), (3) hospitalisation due to non-fatal MI, and (4) hospitalisation due to percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for stable angina among 385,391 combinations in 853 patients. Among these, either plasma BNP levels >200 pg/dl or diuretic use exclusively predicted (1) all-cause hospitalisation, (2) hospitalisation due to worsening of HF, and (3) hospitalisation due to a non-fatal MI, with plasma BNP levels >200 pg/dl being the sole predictor of hospitalisation due to PCI and CABG. Importantly, each finding was verified by independently drawn Kaplan-Meier curves, revealing the unexpected role of plasma BNP levels in the progression of coronary stenosis determined as the necessity of PCI and CABG for stable angina.

Interpretation: In patients with MI and IGT, plasma BNP levels >200 pg/dl predicted the occurrence of coronary stenosis, recurrent MI and worsening of HF, whereas diuretic use did not predict the progression of coronary stenosis but non-fatal MI and worsening of HF We also demonstrated the use of AI in cardiovascular medicine.

Funding: Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan; and Grants-in-Aid from the Japan Agency for Medical Research and Development.  

Declaration of Interest: Relationships to industry do not exist for K.S., H.F., T.H., S.I., A.I., M.A., J.K., H.A., O.T. and T.W. M.K. reports grants and personal fees from Takeda, during the conduct of the study; grants from Japanese government, grants from Japan Heart Foundation, grants from Japan Cardiovascular Research Foundation, grants and personal fees from Asteras, grants and personal fees from Sanofi, personal fees from Daiichi-sankyo, grants and personal fees from Pfizer, grants and personal fees from Ono, personal fees from Bayer, grants and personal fees from Novartis, personal fees from Bheringer, grants and personal fees from Tanabe-mitubishi, personal fees from Kowa, grants and personal fees from Kyowa-hakko-kirin, personal fees from Dainihon-sumitomo, personal fees from Sawai, personal fees from MSD, grants and personal fees from Abott, grants and personal fees from Otsuka, grants from Calpis, grants from Nihon Kohden, personal fees from Shionogi, personal fees from Astrazeneca, personal fees from Asahikasei Med., personal fees from Novo nordisk, personal fees from Fuji-film RI, personal fees from Japan Medical Data, outside the submitted work.

Ethical Approval: Approval had been obtained from the institutional review boards and ethics committees of all involved hospitals. All patients provided written informed consent. The study was performed in accordance with the principles of the Declaration of Helsinki and the Japanese ethical guidelines for clinical research.

Keywords: stable angina, PCI, CABG, coronary artery disease, artificial intelligence

Suggested Citation

Shindo, Kazuhiro and Fukuda, Hiroki and Hitsumoto, Tatsuro and Ito, Shin and Ishii, Akira and Asakura, Masanori and Kim, Jiyoong and Asanuma, Hiroshi and Tsukamoto, Osamu and Washio, Takashi and Kitakaze, Masafumi, Plasma BNP and Diuretics As Predictors of Cardiovascular Events in Patients with MI and IGT (March 26, 2019). Available at SSRN: https://ssrn.com/abstract=3360105 or http://dx.doi.org/10.2139/ssrn.3360105

Kazuhiro Shindo

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Japan

Hiroki Fukuda

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Japan

Tatsuro Hitsumoto

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Japan

Shin Ito

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Japan

Akira Ishii

Osaka University

1-1 Yamadaoka
Suita
Osaka, 565-0871
Japan

Masanori Asakura

Hyogo College of Medicine - Department of Cardiovascular Division

Japan

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Japan

National Cerebral and Cardiovascular Centre - Department of Cardiovascular Medicine

Japan

Hiroshima City Hospital - Department of Cardiology

Japan

Saitama Prefecture Cardiovascular and Respiratory Center - Department of Cardiology

Japan

Jiyoong Kim

Kim Cardiovascular Clinic

Japan

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development

Japan

Hiroshima City Hospital - Department of Cardiology

Japan

Showa Medical University, Showa University Hospital, Department of Medicine, Division of Cardiology

Japan

Hiroshi Asanuma

Meiji University of Intergrative Medicine - Department of Internal Medicine

Japan

Osamu Tsukamoto

Osaka University - Graduate School of Medicine

Osaka
Japan

Takashi Washio

Osaka University

1-1 Yamadaoka
Suita
Osaka, 565-0871
Japan

Masafumi Kitakaze (Contact Author)

National Cerebral and Cardiovascular Centre - Department of Clinical Research and Development ( email )

Japan

Click here to go to TheLancet.com

Paper statistics

Downloads
29
Abstract Views
362
PlumX Metrics